Industries > Pharma > Global Liquid Biopsy Market Forecast 2018-2028

Global Liquid Biopsy Market Forecast 2018-2028

Analysis of the Liquid Biopsy Market by Product, Biomarker, Sample, Cancer and End User, Instruments, Kits and Reagents, Services, Blood Sample, Urine Sample, Circulating Tumour Cell (CTC), Circulating Tumour DNA (ctDNA), Exosomes, Breast Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, Prostate Cancer, Hospitals, Diagnostic Laboratories, Academic Institutions and Cancer Research Centres

PUBLISHED: 24 April 2018
PAGES: 156
PRODUCT CODE: PHA0304
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0304 Categories: , Tags: ,

Liquid Biopsies – our new study reveals trends, R&D progress, and predicted revenues
Where is the liquid biopsy market heading? If you are involved in this sector you must read this brand-new report. Visiongain’s report shows you the potential revenues streams to 2028, assessing data, trends, opportunities and business prospects there.

Discover How to Stay Ahead
Our 156-page report provides 144 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, interviews, trends, opportunities, and revenue predictions. Much opportunity remains in this growing liquid biopsy market. See how to exploit the opportunities.

Forecasts to 2028 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2028, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, you find revenue forecasts for 5 different segmentations of the market, including forecasts for 3 product types, 3 sample types, 3 biomarker types, 6 applications and 4 end users:

• Liquid biopsy Market Forecasts to 2028, By Product Type
• Instruments
• Kits & Reagents
• Services

• Liquid biopsy Market Forecasts to 2028, By Sample Type
• Blood
• Urine
• Other

• Liquid biopsy Technologies Market Forecasts to 2028, By Biomarker Type
• CTC
• ctDNA
• Exosomes

• Liquid biopsy Technologies Market Forecasts to 2028, By Application
• Breast Cancer
• Colorectal Cancer
• Liver Cancer
• Lung Cancer
• Prostate Cancer
• Other Cancers

• Liquid biopsy Technologies Market Forecasts to 2028, By End User
• Hospitals
• Academic Institutes
• Diagnostic Laboratories
• Cancer Research Centres

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts 5 leading regional markets and 19 leading national markets:
• North America
• US
• Canada

• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe

• APAC
• Japan
• China
• India
• South Korea
• Singapore
• Australia & New Zealand

• Rest of APAC
• Latin America
• Brazil
• Argentina
• Rest of Latin America

• MEA
• GCC
• South Africa
• Rest of MEA

Global Liquid Biopsy Market Forecast 2018-2028

There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2028. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.

Leading companies and the potential for market growth
Overall world revenue for liquid biopsy will surpass $600bn in 2018, our work calculates. We predict strong revenue growth through to 2028.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Liquid biopsy Technologies Market report helps you
In summary, our 156-page report provides you with the following knowledge:
• Revenue forecasts to 2028 for the world liquid biopsy market and 5 different segmentations, with 3 product types, 3 sample types, 3 biomarker types, 6 applications and 4 end-user types – discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2028 for the leading 5 regional and 19 national markets North America (US, Canada), Latin America (Brazil, Argentina, Rest of Latin America), Europe (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), APAC (Japan, China, India, South Korea, Singapore, Australia & New Zealand and Rest of APAC), LAMEA (GCC, South Africa and Rest of MEA)
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the <enter sector> market and leading companies. You find data, trends and predictions.

Get our report today Global Liquid Biopsy Market Forecast 2018-2028: Analysis of the Liquid Biopsy Market by Product, Biomarker, Sample, Cancer and End User, Instruments, Kits and Reagents, Services, Blood Sample, Urine Sample, Circulating Tumour Cell (CTC), Circulating Tumour DNA (ctDNA), Exosomes, Breast Cancer, Colorectal Cancer, Liver Cancer, Lung Cancer, Prostate Cancer, Hospitals, Diagnostic Laboratories, Academic Institutions and Cancer Research Centres. Avoid missing out.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

1. Report Overview

1.1 Global Liquid Biopsy Market Overview

1.2 Liquid Biopsy Market Definition & Scope

1.3 Overview of Findings

1.4 Structure of the Report

1.5 Key Questions Answered by This Analytical Report

1.6 How This Report Delivers

1.7 Who is This Report For?

1.8 Methodology

1.8.1 Primary Research

1.8.2 Secondary Research

1.8.3 Market Evaluation & Forecasting Methodology

1.9 Frequently Asked Questions (FAQ)

1.10 Associated Visiongain Reports

1.11 About Visiongain


2. Liquid Biopsy Market Overview

2.1 History of Liquid Biopsies

2.2 Advantages of Liquid Biopsies

2.3 Trends in Liquid Biopsy Market

2.3.1 Companies Increasingly Focusing on Developing Biomarkers Detection Kits

2.3.2 Emergence of Oncogenic Mutations Detection Platforms

2.3.3 Rising Demand for Minimally Invasive Cancer Biomarkers Detecting Procedures

2.4 Market Dynamics

2.4.1 Drivers

2.4.1.1 Rise in global incidence of cancer

2.4.1.2 Increasing Rate of Aging Population

2.4.1.3 Rise in demand for safe and minimally invasive procedures

2.4.1.4 Advantages of liquid biopsy

2.4.2 Restraints

2.4.2.1 Disparity in reimbursements

2.4.2.2 Strict regulatory environment

2.4.3 Opportunities:

2.4.3.1 Increasing involvement of global market players through collaborations/agreements

2.4.3.2 Progress in the development of liquid biopsy tests

2.5 Global Liquid Biopsy Market: Revenue Forecast, 2017-2028


3. Global Liquid Biopsy Market, by Product Type 2018-2028

3.1 Global Liquid Biopsy Market, By Product Type, Revenue Forecast, 2018-2028

3.2 Instruments Segment

3.2.1 Global Liquid Biopsy Market, Instruments Segment Revenue Forecast, 2018-2028

3.3 Kits & Reagents Segment

3.3.1 Global Liquid Biopsy Market, Kits & Reagents Segment Revenue Forecast, 2018-2028

3.4 Services Segment

3.4.1 Global Liquid Biopsy Market, Services Segment Revenue Forecast, 2018-2028

3.5 Market Share Analysis, by Product Type


4. Global Liquid Biopsy Market, by Sample Type 2018-2028

4.1 Global Liquid Biopsy Market, By Sample Type, Revenue Forecast, 2018-2028

4.2 Global Liquid Biopsy Market, Blood Sample Segment Revenue Forecast, 2018-2028

4.3 Global Liquid Biopsy Market, Urine Sample Segment Revenue Forecast, 2018-2028

4.4 Global Liquid Biopsy Market, Other Samples Revenue Forecast, 2018-2028

4.5 Market Share Analysis, by Sample Type


5. Global Liquid Biopsy Market, by Biomarker Type 2018-2028

5.1 Global Liquid Biopsy Market, By Biomarker Type, Revenue Forecast, 2018-2028

5.2 Global Liquid Biopsy Market, Circulating Tumour Cell (CTC) Segment Revenue Forecast, 2018-2028

5.3 Global Liquid Biopsy Market, Circulating Tumour DNA (ctDNA) Segment Revenue Forecast, 2018-2028

5.4 Global Liquid Biopsy Market, Exosomes Segment Revenue Forecast, 2018-2028

5.5 Global Liquid Biopsy Market, Other Biomarkers Segment Revenue Forecast, 2018-2028

5.6 Market Share Analysis, by Biomarker Type


6. Global Liquid Biopsy Market, by Cancer Type 2018-2028

6.1 Global Liquid Biopsy Market, By Cancer Type, Revenue Forecast, 2018-2028

6.2 Global Liquid Biopsy Market, Breast Cancer Segment Revenue Forecast, 2018-2028

6.3 Global Liquid Biopsy Market, Colorectal Cancer Segment Revenue Forecast, 2018-2028

6.4 Global Liquid Biopsy Market, Liver Cancer Segment Revenue Forecast, 2018-2028

6.5 Global Liquid Biopsy Market, Lung Cancer Segment Revenue Forecast, 2018-2028

6.6 Global Liquid Biopsy Market, Prostate Cancer Segment Revenue Forecast, 2018-2028

6.7 Global Liquid Biopsy Market, Other Cancers Segment Revenue Forecast, 2018-2028

6.8 Market Share Analysis, by Cancer Type


7. Global Liquid Biopsy Market, by End User 2018-2028

7.1 Global Liquid Biopsy Market, By End User, Revenue Forecast, 2018-2028

7.2 Global Liquid Biopsy Market, Hospitals Segment Revenue Forecast, 2018-2028

7.3 Global Liquid Biopsy Market, Diagnostic Laboratories Segment Revenue Forecast, 2018-2028

7.4 Global Liquid Biopsy Market, Academic Institutions Segment Revenue Forecast, 2018-2028

7.5 Global Liquid Biopsy Market, Cancer Research Centres Segment Revenue Forecast, 2018-2028

7.6 Market Share Analysis, by End User


8. Global Liquid Biopsy Market, by Leading Nationals 2018-2028

8.1 Global Liquid Biopsy Market, By Leading Nationals, Revenue Forecast, 2018-2028

8.2 North America

8.2.1 North America Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.2.2 North America Liquid Biopsy Market, Revenue Forecast, By Country, 2018-2028

8.2.3 US Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.2.4 Canada Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.2.5 Mexico Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.3 Europe

8.3.1 Europe Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.3.2 Europe Liquid Biopsy Market, Revenue Forecast, By Country, 2018-2028

8.3.3 Germany Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.3.4 France Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.3.5 United Kingdom Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.3.6 United Kingdom Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.3.7 Italy Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.3.8 Spain Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.3.9 Russia Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.4 Asia-Pacific

8.4.1 Asia-Pacific Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.4.2 Asia-Pacific Liquid Biopsy Market, Revenue Forecast, By Country, 2018-2028

8.4.3 Japan Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.4.4 China Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.4.5 Australia Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.4.6 South Korea Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.4.7 India Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.5 LAMEA

8.5.1 LAMEA Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.5.2 LAMEA Liquid Biopsy Market, Revenue Forecast, By Country, 2018-2028

8.5.3 Brazil Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.5.4 Turkey Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.5.5 Venezuela Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.5.6 Saudi Arabia Liquid Biopsy Market, Revenue Forecast, 2018-2028

8.5.7 Republic of South Africa Liquid Biopsy Market, Revenue Forecast, 2018-2028


9. Leading Companies in Liquid Biopsy Market

9.1 Menarini Silicon Biosystems, Inc.

9.1.1 Overview

9.1.2 Technology

9.1.3 Products

9.1.4 Recent Strategic Developments

9.2 MDxHealth SA

9.2.1 Overview

9.2.2 Financials

9.2.3 Products

9.2.4 Recent Strategic Developments

9.3 Biocept, Inc.

9.3.1 Overview

9.3.2 Financials

9.3.3 Products

9.3.4 Recent Strategic Developments

9.4 Trovagene, Inc.

9.4.1 Overview

9.4.2 Technology

9.4.3 Financials

9.4.4 Products

9.4.5 Recent Strategic Developments

9.5 Sysmex Inostics GmbH (A Subsidiary of Sysmex Corporation)

9.5.1 Overview

9.5.2 Technology

9.5.3 Products

9.5.4 Financials

9.5.5 Recent Developments

9.6 F. Hoffmann-La Roche AG

9.6.1 Overview

9.6.2 Financials

9.6.3 Products

9.6.4 Recent Strategic Developments

9.7 Bio-Rad Laboratories, Inc.

9.7.1 Overview

9.7.2 Financials

9.7.3 Products

9.7.4 Recent Strategic Developments

9.8 Guardant Health, Inc.

9.8.1 Overview

9.8.2 Products

9.8.3 Recent Strategic Developments

9.9 Illumina, Inc.

9.9.1 Overview

9.9.2 Financials

9.9.3 Recent Strategic Developments

9.10 Myriad Genetics, Inc.

9.10.1 Overview

9.10.2 Financials

9.10.3 Products

9.10.4 Recent Strategic Developments

9.11 Qiagen N.V.

9.11.1 Overview

9.11.2 Financials

9.11.3 Products

9.11.4 Recent Strategic Developments


10. Qualitative Analysis of the Liquid Biopsy Market

10.1 PESTEL Analysis of the Liquid Biopsy Market

10.1.1 Political

10.1.1.1 Regulatory Bodies:

10.1.1.2 Insurance / Reimbursement:

10.1.2 Economic

10.1.3 Social

10.1.4 Environmental Factors

10.1.5 Technological

10.1.5.1 Decline in use of Old Technologies and Advent of New Technologies

10.1.5.2 Early Stage Diagnosis of Cancer with Liquid Biopsies

10.1.5.3 Improved Liquid Biopsy Techniques

10.1.5.4 Comparison with Tissue Sampling

10.1.5.5 Cost Reductions and Time Saving with Liquid Biopsies

10.1.6 Legal

10.1.6.1 Regulatory Science Challenge

10.1.6.2 FDA

10.1.6.3 Lawsuits and Litigations


11. Conclusion

Associated Visiongain Reports

Visiongain Report Sales Order Form

Appendix A

About Visiongain

Appendix B


Table of Tables

Table 1.1 Global Liquid Biopsy Market Forecast Segmented by Product Type Revenue ($m), AGR (%) and CAGR (%), 2017-2028

Table 2.1: Global Liquid Biopsy Market, Revenue ($m) and AGR (%) 2017-2028

Table 3.1: Global Liquid Biopsy Market, By Product Type, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 3.2: Global Liquid Biopsy Market, Instruments Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 3.3: Global Liquid Biopsy Market, Kits & Reagents Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 3.4: Global Liquid Biopsy Market, Services Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 3.5: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Product Type, 2017, 2023, 2028

Table 4.1: Global Liquid Biopsy Market, By Sample Type, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 4.2: Global Liquid Biopsy Market, Blood Sample Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 4.3: Global Liquid Biopsy Market, Urine Sample Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 4.4: Global Liquid Biopsy Market, Other Samples Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 4.5: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Sample Type, 2017, 2023, 2028

Table 5.1: Global Liquid Biopsy Market, By Biomarker Type, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 5.2: Global Liquid Biopsy Market, Circulating Tumour Cell (CTC) Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 5.3: Global Liquid Biopsy Market, Circulating Tumour DNA (ctDNA) Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 5.4: Global Liquid Biopsy Market, Exosomes Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 5.5: Global Liquid Biopsy Market, Other Biomarkers Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 5.6: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Biomarker Type, 2017, 2023, 2028

Table 6.1: Global Liquid Biopsy Market, By Cancer Type, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 6.2: Global Liquid Biopsy Market, Breast Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 6.3: Global Liquid Biopsy Market, Colorectal Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 6.4: Global Liquid Biopsy Market, Liver Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 6.5: Global Liquid Biopsy Market, Lung Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 6.6: Global Liquid Biopsy Market, Prostate Cancer Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 6.7: Global Liquid Biopsy Market, Other Cancers Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 6.8: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Cancer Type, 2017, 2023, 2028

Table 7.1: Global Liquid Biopsy Market, By End User, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 7.2: Global Liquid Biopsy Market, Hospitals Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 7.3: Global Liquid Biopsy Market, Diagnostic Laboratories Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 7.4: Global Liquid Biopsy Market, Academic Institutions Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 7.5: Global Liquid Biopsy Market, Cancer Research Centres Segment Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 7.6: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by End User, 2017, 2023, 2028

Table 8.1: Global Liquid Biopsy Market, Revenue ($m), Revenue Share (%) by Leading Nationals, 2017, 2023, 2028

Table 8.2: Global Liquid Biopsy Market, By Leading Nationals, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.3: North America Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.4: North America Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%), By Country 2017-2028

Table 8.5: US Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.6: Canada Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.7: Mexico Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.8: Europe Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.9: Europe Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%), By Country 2017-2028

Table 8.10: Germany Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.11: France Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.12: United Kingdom Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.13: United Kingdom Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.14: Italy Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.15: Spain Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.16: Russia Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.17: Asia-Pacific Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.18: Asia-Pacific Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%), By Country 2017-2028

Table 8.19: Japan Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.20: China Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.21: Australia Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.22: South Korea Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.23: India Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.24: LAMEA Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.25: LAMEA Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%), By Country 2017-2028

Table 8.26: Brazil Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.27: Turkey Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.28: Venezuela Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.29: Saudi Arabia Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 8.30: Republic of South Africa Liquid Biopsy Market, Revenue ($m), AGR (%) and CAGR (%) 2017-2028

Table 9.1: Silicon Biosystems Product Portfolio

Table 9.2: Silicon Biosystems Recent Developments

Table 9.3: MDxHealth SA Financials ($m), 2015-2017

Table 9.4: MDxHealth SA Product Portfolio

Table 9.5: MDxHealth SA Recent Developments

Table 9.6: Biocept Financials ($thousand), 2014-2016

Table 9.7: Biocept Product Portfolio

Table 9.8: Biocept Recent Developments

Table 9.9: Trovagene, Inc. Financials ($thousand), 2015-2017

Table 9.10: Trovagene, Inc. Product Portfolio

Table 9.11: Trovagene, Inc. Recent Developments

Table 9.12: Sysmex Inostics Product Portfolio

Table 9.13: Sysmex Inostics Financials ($m), 2015-2017

Table 9.14: Sysmex Inostics GmbH Recent Developments

Table 9.15: Roche Financials ($m), 2015-2017

Table 9.16: Roche Product Portfolio

Table 9.17: Roche Recent Developments

Table 9.18: Bio-Rad Financials ($m), 2014-2016

Table 9.19: Bio-Rad Product Portfolio

Table 9.20: Bio-Rad Recent Developments

Table 9.21: Guardant Product Portfolio

Table 9.22: Guardant Recent Developments

Table 9.23: Illumina Financials ($m), 2014-2016

Table 9.24: Illumina (GRAIL) Recent Developments

Table 9.25: Myriad Financials ($m), 2015-2017

Table 9.26: Myriad Product Portfolio

Table 9.27: Myriad Recent Developments

Table 9.28: Qiagen Financials ($m), 2015-2017

Table 9.29: Qiagen Product Portfolio

Table 9.30: Qiagen Recent Developments


Table of Figures

Figure 2.1 Ageing Population Estimates 2010 - 2050

Figure 2.2: Global Liquid Biopsy Market Revenue ($m), 2017-2028

Figure 3.1: Global Liquid Biopsy Market Revenue ($m), By Product Type, 2017-2028

Figure 3.2: Global Liquid Biopsy Market, Instruments Segment Revenue ($m), 2017-2028

Figure 3.3: Global Liquid Biopsy Market, Kits & Reagents Segment Revenue ($m), 2017-2028

Figure 3.4: Global Liquid Biopsy Market, Services Segment Revenue ($m), 2017-2028

Figure 4.1: Global Liquid Biopsy Market Revenue ($m), By Sample Type, 2017-2028

Figure 4.2: Global Liquid Biopsy Market, Blood Sample Segment Revenue ($m), 2017-2028

Figure 4.3: Global Liquid Biopsy Market, Urine Sample Segment Revenue ($m), 2017-2028

Figure 4.4: Global Liquid Biopsy Market, Other Samples Segment Revenue ($m), 2017-2028

Figure 5.1: Global Liquid Biopsy Market Revenue ($m), By Biomarker Type, 2017-2028

Figure 5.2: Global Liquid Biopsy Market, Circulating Tumour Cell (CTC) Segment Revenue ($m), 2017-2028

Figure 5.3: Global Liquid Biopsy Market, Circulating Tumour DNA (ctDNA) Segment Revenue ($m), 2017-2028

Figure 5.4: Global Liquid Biopsy Market, Exosomes Segment Revenue ($m), 2017-2028

Figure 5.5: Global Liquid Biopsy Market, Other Biomarkers Segment Revenue ($m), 2017-2028

Figure 6.1: Global Liquid Biopsy Market Revenue ($m), By Cancer Type, 2017-2028

Figure 6.2: Global Liquid Biopsy Market, Breast Cancer Segment Revenue ($m), 2017-2028

Figure 6.3: Global Liquid Biopsy Market, Colorectal Cancer Segment Revenue ($m), 2017-2028

Figure 6.4: Global Liquid Biopsy Market, Liver Cancer Segment Revenue ($m), 2017-2028

Figure 6.5: Global Liquid Biopsy Market, Lung Cancer Segment Revenue ($m), 2017-2028

Figure 6.6: Global Liquid Biopsy Market, Prostate Cancer Segment Revenue ($m), 2017-2028

Figure 6.7: Global Liquid Biopsy Market, Other Cancers Segment Revenue ($m), 2017-2028

Figure 7.1: Global Liquid Biopsy Market Revenue ($m), By End User, 2017-2028

Figure 7.2: Global Liquid Biopsy Market, Hospitals Segment Revenue ($m), 2017-2028

Figure 7.3: Global Liquid Biopsy Market, Diagnostic Laboratories Segment Revenue ($m), 2017-2028

Figure 7.4: Global Liquid Biopsy Market, Academic Institutions Segment Revenue ($m), 2017-2028

Figure 7.5: Global Liquid Biopsy Market, Cancer Research Centres Segment Revenue ($m), 2017-2028

Figure 8.1: Global Liquid Biopsy Market Revenue ($m), By Leading Nationals, 2017-2028

Figure 8.2: North America Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.3: US Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.4: Canada Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.5: Mexico Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.6: Europe Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.7: Germany Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.8: France Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.8: United Kingdom Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.9: United Kingdom Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.10: Italy Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.11: Spain Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.12: Russia Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.13: Asia-Pacific Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.14: Japan Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.15: China Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.16: Australia Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.17: South Korea Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.18: India Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.19: LAMEA Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.20: Brazil Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.21: Turkey Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.22: Venezuela Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.23: Saudi Arabia Liquid Biopsy Market, Revenue ($m), 2017-2028

Figure 8.24: Republic of South Africa Liquid Biopsy Market, Revenue ($m), 2017-2028

Astellas

AstraZeneca

Bio Rad Laboratories Inc

Biocept Inc

Bristol Myers Squibb

Catalyst Pharmaceuticals

Cerba Healthcare

Clearbridge BioMedics (Singapore)

Clinical Genomics

Clovis Oncology

Daiichi Sankyo

Foundation Medicine, Inc.

G-TAC Co., Ltd. (Japan)

Guardant Health Inc

HarlePhil Ventures

HistoGeneX N.V

Illumina Inc

Inostics GmbH

Janssen

LabCorp (U.S.)

M3, Inc. (U.S.).

Maccura Biotechnology Co., Ltd.

MDxHealth SA

MedNcrease Health Plans LLC

Menarini Group

Merck KGaA

Merck Serono (Switzerland)

Miraca Life Sciences

Myriad Genetics

Myriad Genetics, Inc.

Natera, Inc.

NovioGendix Holding B.V

Novogene Co. Ltd

OncoMed Pharmaceuticals

Pathway Genomics Corporation

Pfizer

Qiagen N.V

Roche Holding AG

Silicon Biosystems

Silicon Biosystems S.p.A

SouthGenetics

Swift Biosciences

Sysmex Inostics GmbH

Teva Pharmaceuticals

Trovagene

Unilabs


Organisations Mentioned in This Report

Addario Lung Cancer Medical Institute

Centre for Medicare and Medicaid Services (CMS)

Dana-Farber Cancer Institute (U.S.)

European Databank on Medical Devices (EUDAMED)

Japanese Ministry of Health Labour and Welfare (MHLW)

Japanese Pharmaceuticals and Medical Devices Agency (PMDA)

Ministry of Health (China)

National Cancer Center East Japan

National Health Laboratory of Myanmar

National Institute of Statistics and Economic Studies

OHSU Knight Cancer Institute

UK National Health Service (NHS)

United Nations (UN)

University of California (U.S.)

University of Michigan Comprehensive Cancer

University of Michigan Comprehensive Cancer Center

University of Southern California (U.S.)

University of Tokyo

US Food and Drug Administration (FDA)

US Oncology Research

USC Norris Comprehensive Cancer Center

World Health Organization (WHO)

Download sample pages

Complete the form below to download your free sample pages for Global Liquid Biopsy Market Forecast 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global Liquid Biopsy Market Forecast 2018-2028


facebookWin a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.

Click here to ‘Like’ our Facebook page https://www.facebook.com/V.G.Pharma/

Would you like a free report overview of the report of your choice?

If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com

Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Would you like to get the latest Visiongain pharma reports catalogue?

What are the dynamic growth sectors? where are the regional business opportunities?

Which technologies will prevail and who are the leading companies succeeding in these sectors and why?

If you want definitive answers to business critical questions, discover Visiongain’s full range of business intelligence reports.

If so, please email Sara Peerun on sara.peerun@visiongain.com or call her today on +44 (0) 20 7549 9987

  • Top 20 Asthma & COPD Companies 2019
  • Human Microbiome Therapeutics Market 2019-2029
  • Top 20 Urology Companies 2019
  • Global Antidepressant and Anti-Anxiety Drugs Market Forecasts 2019-2029
  • The Top 100 In-Vitro Diagnostics Companies to Watch 2019
  • Global Hypertension Drugs Market 2019-2029
  • Rheumatoid Arthritis Market 2019-2029
  • The Next Generation Sequencing Market 2019-2029
  • Lyophilisation for Pharmaceuticals: Products and Services 2019-2029
  • Global Cancer Immunotherapy Market 2019-2029
  • Top 25 In Vitro Diagnostics (IVD) Companies 2019
  • Global Anti-Idiopathic Pulmonary Fibrosis Drugs Market 2019-2029
  • Global Biomarkets and Technologies Market 2019-2029
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Kuwait Pharmaceutical Association
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Generic Medicines Association
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Latest Pharma news

“Global Neurostimulation Devices market set to grow to $13bn by 2024” says new Visiongain report

Neurostimulation is an advanced treatment which helps to reduce certain types of chronic pain.

28 November 2018

READ

“Global Anti-Obesity Drugs market set to grow to $6.3bn by 2023” says new Visiongain report

Most of the anti-obesity drugs have gone off-patent and thus this drug market is also marketed in to two markets as Innovator and Branded drugs.

20 November 2018

READ

“Global Laboratory Information Systems market set to grow to $2.8bn by 2023” says new Visiongain report

The laboratory information system (“LIS”) industry includes set of programs and hardware, which are part of an integrated system designed for healthcare information.

19 November 2018

READ

“Global Biologics market set to grow to $250bn by 2023” says Visiongain

Bio therapeutics is the fastest-growing sector in the pharmaceutical industry, with total revenues reaching up to $163 billion.

14 November 2018

READ

Categories

Category